Concepedia
Statistics
Publications
2
Citations
62
H-Index
Active since
2018
Affiliations
Heidelberg University(Current)
Technical University of Munich
Klinik Donaustauf
German Cancer Research Center
Munich Leukemia Laboratory (Germany)
Richard Hauch is an author at Heidelberg University specializing in myelodysplastic syndrome treatment, medicine, and hematology.
Publications per year
2018–2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Stefanie Jilg, Richard Hauch, Johanna Kauschinger et al. · Experimental Hematology and Oncology · 2019 · 40 citations · Full text
Medicine, Hematology, Pharmacotherapy +16
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Veronika Reidel, Johanna Kauschinger, Richard Hauch et al. · Oncotarget · 2018 · 22 citations · Full text
Medicine, Hematology, Oncology +16
1–2 of 2